Search results for:
meropenem
meropenem
| Drug Name |
Form |
Strength |
Non-Formulary |
Restricted |
TX Sub |
Notes |
| Merrem |
POWDER FOR INJECTION, INTRAVENOUS |
500 mg; 1 g; 2g |
|
|
|
|
Last updated: Mar. 17, 2025
- Renal Adjustment Policy meropenem subject to adjustments by pharmacy.
(Brand)
• Indications
Comments
(Merrem©)
• CNS infections
• Necrotizing fasciitis
• Bone/Joint Infection
(3 hr infusion)
Refer to
CrCl 25-49 mL/min: 2 gm q12h
CrCl 10-24 mL/min: 1 gm q12h
CrCl < 10 mL/min, HD: 1 gm q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 2 gm q12h
(Merrem©)
• Pseudomonas infection
(susceptible to meropenem)
• Acinetobacter infection
(susceptible to meropenem)
(3 hr infusion)
Refer to
CrCl 25-49 mL/min: 1 gm q12h
CrCl 10-24 mL/min: 500 mg q12h
CrCl < 10 mL/min, HD: 500 mg q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 1 gm q12h
(Merrem©)
• Pneumonia
• Intra-abdominal infection
• Neutropenic fever
• Infections caused by ESBLs or cefTRIAXone-resistant organisms
(30 min infusion)
Refer to
CrCl 25-49 mL/min: 500 mg q8h
CrCl 10-24 mL/min: 500 mg q12h
CrCl < 10 mL/min, HD: 500 mg q24h (give dose after HD)
Continuous renal replacement therapy
(CRRT): 500 mg q6h